...
tsbx-img

Turnstone Biologics Corp. Common Stock, Common Stock

TSBX

NMQ

$0.463

-$0.04

(-7.97%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$13.39M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
22.30K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.4 L
$5.75 H
$0.463

About Turnstone Biologics Corp. Common Stock, Common Stock

Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, head and neck cancer and uveal melanoma, as well as an investigator sponsored trials to treat colorectal cancer, head and neck cancer, and cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTSBXSectorS&P500
1-Week Return-1.57%-3.39%0.2%
1-Month Return6.79%-1.92%2.72%
3-Month Return-22.92%-10.54%7.31%
6-Month Return-81.41%-4.47%10.44%
1-Year Return-77.39%4.06%27.53%
3-Year Return-95.82%0.94%30.88%

Financials

Dec '21Dec '22Dec '23
Total Revenue101.29M73.30M19.31M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":72.36,"profit":true},{"date":"2023-12-31","value":19.06,"profit":true}]
Cost of Revenue2.01M2.20M2.80M[{"date":"2021-12-31","value":71.86,"profit":true},{"date":"2022-12-31","value":78.57,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit99.28M71.10M16.51M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":71.61,"profit":true},{"date":"2023-12-31","value":16.63,"profit":true}]
Gross Margin98.01%97.00%85.50%[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.96,"profit":true},{"date":"2023-12-31","value":87.23,"profit":true}]
Operating Expenses68.30M104.93M78.34M[{"date":"2021-12-31","value":65.09,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":74.66,"profit":true}]
Operating Income32.99M(31.63M)(59.03M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-95.86,"profit":false},{"date":"2023-12-31","value":-178.92,"profit":false}]
Total Non-Operating Income/Expense---[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income33.70M(30.69M)(55.49M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-91.07,"profit":false},{"date":"2023-12-31","value":-164.64,"profit":false}]
Income Taxes432.00K141.00K(286.00K)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":32.64,"profit":true},{"date":"2023-12-31","value":-66.2,"profit":false}]
Income After Taxes---[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations33.27M(30.83M)(52.42M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-92.68,"profit":false},{"date":"2023-12-31","value":-157.56,"profit":false}]
Income From Discontinued Operations---[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income33.27M(30.83M)(55.20M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-92.68,"profit":false},{"date":"2023-12-31","value":-165.92,"profit":false}]
EPS (Diluted)--(9.29)[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-929,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TSBX
Cash Ratio 3.32
Current Ratio 3.75

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TSBX
ROA (LTM) -66.10%
ROE (LTM) -134.46%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TSBX
Debt Ratio Lower is generally better. Negative is bad. 0.25
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.75

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TSBX
Trailing PE NM
Forward PE NM
P/S (TTM) 2.13
P/B 0.25
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.80

FAQs

What is Turnstone Biologics Corp. Common Stock share price today?

Turnstone Biologics Corp. Common Stock (TSBX) share price today is $0.463

Can Indians buy Turnstone Biologics Corp. Common Stock shares?

Yes, Indians can buy shares of Turnstone Biologics Corp. Common Stock (TSBX) on Vested. To buy Turnstone Biologics Corp. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TSBX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Turnstone Biologics Corp. Common Stock be purchased?

Yes, you can purchase fractional shares of Turnstone Biologics Corp. Common Stock (TSBX) via the Vested app. You can start investing in Turnstone Biologics Corp. Common Stock (TSBX) with a minimum investment of $1.

How to invest in Turnstone Biologics Corp. Common Stock shares from India?

You can invest in shares of Turnstone Biologics Corp. Common Stock (TSBX) via Vested in three simple steps:

  • Click on Sign Up or Invest in TSBX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Turnstone Biologics Corp. Common Stock shares
What is Turnstone Biologics Corp. Common Stock 52-week high and low stock price?

The 52-week high price of Turnstone Biologics Corp. Common Stock (TSBX) is $5.75. The 52-week low price of Turnstone Biologics Corp. Common Stock (TSBX) is $0.4.

What is Turnstone Biologics Corp. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Turnstone Biologics Corp. Common Stock (TSBX) is

What is Turnstone Biologics Corp. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Turnstone Biologics Corp. Common Stock (TSBX) is 0.25

What is Turnstone Biologics Corp. Common Stock dividend yield?

The dividend yield of Turnstone Biologics Corp. Common Stock (TSBX) is 0.00%

What is the Market Cap of Turnstone Biologics Corp. Common Stock?

The market capitalization of Turnstone Biologics Corp. Common Stock (TSBX) is $13.39M

What is Turnstone Biologics Corp. Common Stock’s stock symbol?

The stock symbol (or ticker) of Turnstone Biologics Corp. Common Stock is TSBX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top